Studies showed gender-associated differences in multiple sclerosis (MS) disease evolution and in the evolution of conventional magnetic resonance imaging (MRI) findings.
Objective
The aim of this study was to investigate gender differences according to a number of conventional and nonconventional MRI measures in patients with MS.
Methods
We examined 763 consecutive patients with MS [499 (19.2% men) relapsing-remitting (RR), 230 (24.8% men) secondary-progressive, and 34 (44.1% men) primary-progressive], 32 (21.9% men) patients with clinically isolated syndrome (CIS), and 101 (30.7% men) normal controls (NC). Patients were assessed using conventional and nonconventional MRI measures. Gender-related MRI differences were investigated using general linear model analysis, corrected for MS disease type.
Results
In the total MS group, male patients showed lower normalized peripheral gray matter (GM) (P < 0.001) and normalized GM (P = 0.011) volumes than female patients. Female patients presented lower normalized white matter (WM) volumes (P = 0.011). These gender effects were not observed in NC. Male patients also showed more advanced central atrophy (P = 0.022). In RRMS male patients, there was also a higher lateral ventricle volume (P = 0.001). The GM-WM normalized ratio was lower for male patients with MS compared with male NC (0.97 vs. 1.09, P < 0.001) but not in patients with CIS compared with NC.
Conclusions
There were no significant gender-related differences regarding nonconventional MRI measures. GM and central atrophy are more advanced in male patients, whereas WM atrophy is more advanced in female patients. These gender-related MRI differences may be explained by the effect of sex hormones on brain damage and repair mechanisms.
1 Whitacre CC Reingold SC O'Looney PA . A gender gap in autoimmunity. Science1999; 283: 1277–1278.
2.
2 Hawkins SA McDonnell GV . Benign multiple sclerosis? clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry1999; 67: 148–152.
3.
3 Confavreux C Hutchinson M Hours M Cortinovis-Tourniaire P Moreau T . Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in multiple sclerosis group. N Engl J Med1998; 339: 285–291.
4.
4 Kantarci O Siva A Eraksoy M . Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG). Neurology1998; 51: 765–772.
5.
5 Pozzilli C Tomassini V Marinelli F Paolillo A Gasperini C Bastianello S . ‘Gender gap’ in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol2003; 10: 95–97.
6.
6 Li DK Zhao GJ Paty DW . Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results. Neurology2001; 56: 1505–1513.
7.
7 van Walderveen MA Lycklama ANGJ Ader HJ . Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. Arch Neurol2001; 58: 76–81.
8.
8 Weatherby SJ Mann CL Davies MB . A pilot study of the relationship between gadolinium-enhancing lesions, gender effect and polymorphisms of antioxidant enzymes in multiple sclerosis. J Neurol2000; 247: 467–470.
9.
9 Rovaris M Gass A Bammer R . Diffusion MRI in multiple sclerosis. Neurology2005; 65: 1526–1532.
10.
10 Horsfield MA . Magnetization transfer imaging in multiple sclerosis. J Neuroimaging2005; 15: 58S–67S.
11.
11 Zivadinov R Reder AT Filippi M . Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology2008; 71: 136–144.
12.
12 Good CD Johnsrude IS Ashburner J Henson RN Friston KJ Frackowiak RS . A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage2001; 14: 21–36.
13.
13 Zivadinov R . Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? Neurology2007; 68: S72–S82.
14.
14 Pirko I Lucchinetti CF Sriram S Bakshi R . Gray matter involvement in multiple sclerosis. Neurology2007; 68: 634–642.
15.
15 Cosgrove KP Mazure CM Staley JK . Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry2007; 62: 847–855.
16.
16 Allen JS Damasio H Grabowski TJ Bruss J Zhang W . Sexual dimorphism and asymmetries in the gray-white composition of the human cerebrum. Neuroimage2003; 18: 880–894.
17.
17 Good CD Johnsrude I Ashburner J Henson RN Friston KJ Frackowiak RS . Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage2001; 14: 685–700.
18.
18 Polman CH Reingold SC Edan G . Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol2005; 58: 840–846.
19.
19 Lublin FD Reingold SC . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology1996; 46: 907–911.
20.
20 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983; 33: 1444–1452.
21.
21 Zivadinov R Rudick RA De Masi R . Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology2001; 57: 1239–1247.
22.
22 Zivadinov R Bagnato F Nasuelli D . Short-term brain atrophy changes in relapsing-remitting multiple sclerosis. J Neurol Sci2004; 223: 185–193.
23.
23 Smith SM Zhang Y Jenkinson M . Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage2002; 17: 479–489.
24.
24 Benedict R Bruce J Dwyer M Abderlahman N Zivadinov R . Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. Arch Neurol2006; 63: 1301–1306.
25.
25 Tavazzi E Dwyer MG Weinstock-Guttman B . Quantitative diffusion weighted imaging measures in patients with multiple sclerosis. Neuroimage2007; 36: 746–754.
26.
26 Zivadinov R Weinstock-Guttman B Benedict R . Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Hum Mol Genet2007; 16: 2659–2668.
27.
27 Kutzelnigg A Lucchinetti CF Stadelmann C . Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain2005; 128: 2705–2712.
28.
28 Dutta R Trapp BD . Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology2007; 68: S22–S31 [discussion S43–S54].
29.
29 Magliozzi R Howell O Vora A . Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain2007; 130: 1089–1104.
30.
30 Peeva E Zouali M . Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett2005; 101: 123–143.
31.
31 Kanda N Tsuchida T Tamaki K . Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum1997; 40: 1703–1711.
32.
32 Sicotte NL Giesser BS Tandon V . Testosterone treatment in multiple sclerosis: a pilot study. Arch Neurol2007; 64: 683–688.
33.
33 Patwardhan AJ Eliez S Bender B Linden MG Reiss AL . Brain morphology in Klinefelter syndrome: extra X chromosome and testosterone supplementation. Neurology2000; 54: 2218–2223.
34.
34 Cutter WJ Daly EM Robertson DM . Influence of X chromosome and hormones on human brain development: a magnetic resonance imaging and proton magnetic resonance spectroscopy study of Turner syndrome. Biol Psychiatry2006; 59: 273–283.
35.
35 Tomassini V Onesti E Mainero C . Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry2005; 76: 272–275.
36.
36 Tomassini V Pozzilli C . Sex hormones: a role in the control of multiple sclerosis? Expert Opin Pharmacother2006; 7: 857–868.
37.
37 Sicotte NL Liva SM Klutch R . Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol2002; 52: 421–428.
38.
38 Wegmann TG Lin H Guilbert L Mosmann TR . Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today1993; 14: 353–356.
39.
39 Pozzilli C Falaschi P Mainero C . MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormone patterns. Neurology1999; 53: 622–624.
40.
40 van Walderveen MA Tas MW Barkhof F . Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology1994; 44: 327–329.
41.
41 Gregg C Shikar V Larsen P . White matter plasticity and enhanced remyelination in the maternal CNS. J Neurosci2007; 27: 1812–1823.
42.
42 Nguyen LT Ramanathan M Weinstock-Guttman B Baier M Brownscheidle C Jacobs LD . Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients. J Neurol Sci2003; 209: 93–99.
43.
43 Moldovan IR Cotleur AC Zamor N Butler RS Pelfrey CM . Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens. J Neuroimmunol2008; 193: 161–169.
44.
44 Tiberio M Chard DT Altmann DR . Gray and white matter volume changes in early RRMS: a 2-year longitudinal study. Neurology2005; 64: 1001–1007.
45.
45 Horakova D Cox JL Havrdova E . Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years. A case control study. J Neurol Neurosurg Psychiatry2008; 79: 407–414.
46.
46 Redmond IT Barbosa S Blumhardt LD Roberts N . Short-term ventricular volume changes on serial MRI in multiple sclerosis. Acta Neurol Scand2000; 102: 99–105.
47.
47 Zivadinov R Bakshi R . Role of MRI in multiple sclerosis II: brain and spinal cord atrophy. Front Biosci2004; 9: 647–664.
48.
48 Wolinsky JS Narayana PA O'Connor P . Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial. Ann Neurol2007; 61: 14–24.
49.
49 Sarchielli P Zaffaroni M Floridi A . Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-{beta} 1a, and high doses of immunoglobulins. Mult Scler2007; 13: 313–331.
50.
50 Weinstock-Guttman B Zivadinov R Tamano-Blanco M . Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis. J Neuroimmunol2007; 188: 167–174.
